Oramed Pharmaceuticals Inc. (ORMP)

NASDAQ: ORMP · Real-Time Price · USD

Compare

3.680

-0.010 (-0.27%)

At close: Jan 16, 2026, 4:00 PM EST

3.710

+0.030 (0.82%)

After-hours: Jan 16, 2026, 7:32 PM EST

Oramed Pharmaceuticals Market Cap

Oramed Pharmaceuticals has a market cap or net worth of $146.47 million as of January 16, 2026. Its market cap has increased by 50.07% in one year.

Market Cap

146.47M

Enterprise Value

12.65M

1-Year Change

50.07%

Ranking

#4031

Market Cap Chart

Since May 31, 2007, Oramed Pharmaceuticals's market cap has increased from $29.90M to $146.47M, an increase of 389.88%. That is a compound annual growth rate of 8.90%.

Market Cap History

Date	Market Cap	% Change
Jan 16, 2026	146.50M	29.19%
Dec 31, 2025	113.40M	16.19%
Dec 31, 2024	97.60M	4.72%
Dec 29, 2023	93.20M	-80.20%
Dec 30, 2022	470.60M	-13.48%
Dec 31, 2021	543.90M	441.73%
Dec 31, 2020	100.40M	12.05%
Dec 31, 2019	89.60M	71.98%
Dec 31, 2018	52.10M	-59.55%
Dec 29, 2017	128.80M	58.62%
Dec 30, 2016	81.20M	-18.15%
Dec 31, 2015	99.20M	115.18%
Dec 31, 2014	46.10M	-62.40%
Dec 31, 2013	122.60M	330.18%
Dec 31, 2012	28.50M	45.41%
Dec 30, 2011	19.60M	11.36%
Dec 31, 2010	17.60M	-31.52%
Dec 31, 2009	25.70M	16.82%
Dec 31, 2008	22.00M	83.33%
Dec 31, 2007	12.00M	-59.87%
May 31, 2007	29.90M	-

View and export this data all the way back to 2007. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Eli Lilly and Company	929.76B
Johnson & Johnson	526.82B
AbbVie	378.84B
UnitedHealth Group	299.85B
AstraZeneca	291.69B
Novartis AG	276.38B
Merck & Co.	270.12B
Novo Nordisk	268.23B

Market Cap Rankings